Expression of p21 Waf1 , p27 Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ : Relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status-Reference-Cited by-同舟云学术

Expression of p21 Waf1 , p27 Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ : Relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status

Published:2001-02 Issue:2 Volume:51 Page:94-99
ISSN:1320-5463
Container-title:Pathology International
language:en
Short-container-title:Pathology International

Author:

Oh Young Lyun¹,Choi Jong Sun¹,Song Sang‐Yong¹,Ko Young Hyeh¹,Han Boo‐Kyung²,Nam Seok‐Jin³,Yang Jung‐Hyun³

Affiliation:

1. Departments of Diagnostic Pathology,

2. Radiology and

3. General Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Publisher

Wiley

Subject

General Medicine,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1440-1827.2001.01173.x

Reference39 articles.

1. Cyclins, Cyclin-Dependent Kinases and Cdk Inhibitors: Implications in Cell Cycle Control and Cancer

2. p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival

3. Prognostic value of p21 WAF1 and p53 expression in breast carcinoma: An immunohistochemical study in 261 patients with long‐term follow‐up.;Caffo O;Clin. Cancer Res.,1996

4. p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circadian rhythms of proliferation events in two mouse carcinomas;Biological Rhythm Research;2015-04-23

2. Prognostic Value of p53 and Cyclin D1 in Papillary Thyroid Carcinoma;Korean Journal of Endocrine Surgery;2015

3. The prognostic value of apoptotic and proliferative markers in breast cancer;Breast Cancer Research and Treatment;2013-11

4. Prognostic value of molecular markers and cytogenetic alterations that characterize breast cancer precursor lesions (Review);Oncology Letters;2013-09-17

5. Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinomain situ;Expert Review of Molecular Diagnostics;2013-03